| Literature DB >> 14733836 |
Brian R Matlaga1, Ronald J Zagoria, Peter E Clark, M Craig Hall.
Abstract
Radiofrequency ablation (RFA) of renal tumors is a relatively new treatment modality in the armamentarium of urologic surgeons. One of the challenges of this technique is attaining a zone of tissue destruction sufficient enough to kill the targeted tumor. Technologic innovations have aided in this effort. The clinical experience with RFA of renal tumors suggests that small, exophytic tumors may be more readily ablated. Although there is much optimism with regard to this technology, further study is required to better define the oncologic efficacy and refine proper patient selection.Entities:
Mesh:
Year: 2004 PMID: 14733836 DOI: 10.1007/s11934-004-0010-1
Source DB: PubMed Journal: Curr Urol Rep ISSN: 1527-2737 Impact factor: 3.092